He & She MD vs Telos Rx: Pricing, Coaching, and Clinician Review
Quick verdict: He & She MD emphasizes bundled coaching and 1:1 clinician messaging with compounded GLP-1s at six-month intro rates, while Telos Rx advertises lower “as low as” monthly prices that are subject to approval by a US-licensed provider. This comparison focuses on pricing structure, coaching and clinician access, medication formats, regulatory notes, and cancellation or renewal terms for He & She MD vs Telos Rx.
Check He & She MD pricing and app features
He & She MD vs Telos Rx: pricing approach and introductory rates
He & She MD lists compounded semaglutide injections starting at $139 per month and oral semaglutide or tirzepatide injections at $199 per month, each described as six-month introductory rates that renew higher. Telos Rx presents semaglutide “as low as” $99 per month and tirzepatide as low as $139 per month, with final pricing “if a licensed provider approves you” and notes that your price depends on your plan.
See Telos Rx estimated prices and eligibility
Distinctive differences organized by evidence
1) Pricing presentation and term structure
He & She MD advertises specific six-month introductory prices ($139/mo semaglutide injections; $199/mo oral semaglutide and tirzepatide injections) and warns those promo rates renew at higher six-month prices. Telos Rx emphasizes “as low as” monthly pricing and that treatment is available only after review by a US-licensed provider, with final price depending on the plan and approval.
View He & She MD introductory rates
2) Coaching, clinician access, and care model
He & She MD bundles a coaching app with 1:1 clinician messaging and GLP-1-specific guidance and progress tracking at no extra cost, positioning that support as part of the program. Telos Rx describes care from a licensed provider who decides which molecule is right, but the captured evidence does not document a bundled coaching app or 1:1 messaging included.
3) Medication formats and provider selection
He & She MD explicitly sells semaglutide injection, oral semaglutide, or tirzepatide injection within its programs. Telos Rx advertises compounded semaglutide and tirzepatide options and notes tirzepatide acts on GLP-1 and GIP, with a US-licensed provider deciding which medication is appropriate.
4) Regulatory and pharmacy notes
Both providers’ captured evidence states these are compounded medications and notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. He & She MD additionally states medications are produced in USP-compliant, state-regulated pharmacies but not reviewed by the FDA.
5) Cancellation, renewal and commitments
He & She MD frames pricing as structured in six-month terms with promotional introductory rates that renew higher after the first six months. Telos Rx materials indicate “cancel anytime, no penalties” in the captured content, but also emphasize that price, eligibility, and state coverage may change and final terms depend on clinician approval.
| Criteria | He & She MD | Telos Rx |
|---|---|---|
| Starting price (captured) | Semaglutide injections start at $139/mo (six-month intro rate) | Semaglutide as low as $99/mo (subject to provider approval) |
| Medication formats | Semaglutide injection, oral semaglutide, tirzepatide injection | Compounded semaglutide and tirzepatide; provider selects molecule |
| Coaching and clinician access | Coaching app with 1:1 clinician messaging and tracking included | Prescribed online by a US-licensed provider; bundled coaching not documented |
| Pricing terms | Six-month introductory rates; renew higher after first six months | “As low as” pricing; final price depends on plan and clinician approval |
| Regulatory note | Compounded meds not reviewed by FDA; produced in USP-compliant pharmacies | Compounded meds not FDA-approved and not reviewed by FDA |
| Cancellation | Structured as six-month terms rather than month-to-month | Captured content states cancel anytime, no penalties; terms subject to change |
How to decide: practical guidance for He & She MD vs Telos Rx
If your priority is bundled coaching and integrated 1:1 clinician messaging with a clear six-month introductory price, He & She MD is presented as the option that includes app-based coaching and progress tracking at no extra cost. If your priority is the lowest advertised starting monthly price and flexibility in plan cancellation, Telos Rx shows lower “as low as” pricing for semaglutide and tirzepatide but final pricing and eligibility are subject to clinician approval.
Check Telos Rx clinician approval and pricing details
Compare He & She MD plans and eligibility
Choose He & She MD if…
You want compounded GLP-1 medications bundled with a coaching app, 1:1 clinician messaging and GLP-1-specific tracking included at no extra cost, and you accept six-month introductory rates that renew higher.
Choose Telos Rx if…
You prioritize lower advertised “as low as” monthly pricing for semaglutide or tirzepatide and want a plan where final price and medication are determined after review by a US-licensed provider.